Evidence map›Paper›PMID 35222429›Full record

ArticleFrontiers in immunology2022

Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults.

Lise Lund Berven, Joel Selvakumar, Lise Havdal, Tonje Stiansen-Sonerud, Gunnar Einvik, Truls Michael Leegaard, Trygve Tjade, Annika E Michelsen, Tom Eirik Mollnes, Vegard Bruun Bratholm Wyller

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04686734 completednot on this map

Long-term Effects of COVID-19 in Adolescents

TypeobservationalSponsorUniversity Hospital, AkershusRan2021 to 2022Enrolled516ConditionsCovid19ArmsNo active intervention (observational only)
NCT05381714 completednot on this map

Long-Term Respiratory and Peripheral Muscle Strength and Respiratory Function in Young COVID-19 Patients: A Cross-Sectional Study

Typeobservational_patient_registrySponsorKarabuk UniversityRan2022 to 2023Enrolled100ConditionsCOVID-19
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lise Lund BervenDepartment of Paediatrics, Akershus University Hospital, Lørenskog, Norway.
Joel SelvakumarInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lise HavdalDepartment of Paediatrics, Akershus University Hospital, Lørenskog, Norway.
Tonje Stiansen-SonerudDepartment of Paediatrics, Akershus University Hospital, Lørenskog, Norway.
Gunnar EinvikInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Truls Michael LeegaardInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Trygve TjadeFürst Medical Laboratory, Oslo, Norway.
Annika E MichelsenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tom Eirik MollnesDepartment of Immunology, University of Oslo, Oslo, Norway.
Vegard Bruun Bratholm WyllerDepartment of Paediatrics, Akershus University Hospital, Lørenskog, Norway.
Akershus University Hospital · NOUniversity of Oslo · NONordland Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: Mild, subacute COVID-19 in young people show inflammatory enhancement, but normal pulmonary function. Inflammatory markers are associated with age and male sex, whereas clinical symptoms are associated with age and female sex, but not with objective disease markers. Background: Coronavirus Disease 2019 (COVID-19) is widespread among adolescents and young adults across the globe. The present study aimed to compare inflammatory markers, pulmonary function and clinical symptoms across non-hospitalized, 12 - 25 years old COVID-19 cases and non-COVID-19 controls, and to investigate associations between inflammatory markers, clinical symptoms, pulmonary function and background variables in the COVID-19 group. Methods: The present paper presents baseline data from an ongoing longitudinal observational cohort study (Long-Term Effects of COVID-19 in Adolescents, LoTECA, ClinicalTrials ID: NCT04686734). A total of 31 plasma cytokines and complement activation products were assayed by multiplex and ELISA methodologies. Pulmonary function and clinical symptoms were investigated by spirometry and questionnaires, respectively. Results: A total of 405 COVID-19 cases and 111 non-COVID-19 controls were included. The COVID-19 group had significantly higher plasma levels of IL-1β, IL-4, IL-7, IL-8, IL-12, TNF, IP-10, eotaxin, GM-CSF, bFGF, complement TCC and C3bc, and significantly lower levels of IL-13 and MIP-1α, as compared to controls. Spirometry did not detect any significant differences across the groups. IL-4, IL-7, TNF and eotaxin were negatively associated with female sex; eotaxin and IL-4 were positively associated with age. Clinical symptoms were positively associated with female sex and age, but not with objective disease markers. Conclusions: Among non-hospitalized adolescents and young adults with COVID-19 there was significant alterations of plasma inflammatory markers in the subacute stage of the infection. Still, pulmonary function was normal. Clinical symptoms were independent of inflammatory and pulmonary function markers, but positively associated with age and female sex.

Indexed as

Acute DiseaseAdolescentAdultBiomarkersChildCOVID-19FemaleHospitalizationHumansInflammation MediatorsLungMaleRespiratory Function TestsSARS-CoV-2Young AdultBiomarkersInflammation Mediatorsadolescentscohort studyinflammatory markersnon-hospitalizedSARS-CoV-2

Identifiers

PMID35222429
PMCPMC8864121
OpenAlexW4211096971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.